Bioprocess Online: BIO 2026: Crowley On Competing With China And Modernizing The FDA

According to Crowley, this program was informed by a white paper BIO provided to former FDA commissioner Marty Makary last fall, as well as a subsequent working session with the Reagan-Udall Foundation and top leadership from the FDA’s drug and biologics divisions.